The morning after the world learned that a closely watched clinical trial of a coronavirus vaccine had been halted last week over safety concerns, the company’s chief executive disclosed that a person given the vaccine had experienced serious neurological symptoms.
Image: Pascal Soriot, chief executive of the drug company AstraZeneca, in Washington in February.Credit…Erin Schaff/The New York Times
{iframe}https://www.nytimes.com/2020/09/13/science/coronavirus-vaccine-trials.html{/iframe}